Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

FY 2017 Labor/HHS Appropriations, provisions relating to antimicrobial resistance
Bipartisan Budget Act (Section 603), provisions relating to site of service payment
FY 2017 Labor/HHS Appropriations, Diabetes prevention funding

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

Higher Education Reauthorization
Graduate Medical Education

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 1270, Restoring Access to Medication Act of 2015, all provisions
S. 709, Restoring Access to Medication Act of 2015, all provisions
S. 524, Comprehensive Addiction and Recovery Act of 2015, all provisions
S. 2256, Co-Prescribing Saves Lives Act of 2015, all provisions
S. 2687, Plan of Safe Care Improvement Act, all provisions
S. 2680, Mental Health Reform Act of 2016, all provisions
S. 1945, Mental Health Reform Act of 2015, all provisions
H.R. 2646, Helping Families in Mental Health Crisis Act of 2015, all provisions
H.R. 1725, National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2015, all provisions
S. 480, National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2015, all provisions
H.R. 2536, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions
S. 1455, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions
H.R. 2872, Opioid Addiction Treatment Modernization Act, all provisions
H.R. 4599, Reducing Unused Medications Act of 2016, all provisions
S. 2578, Reducing Unused Medications Act of 2016, all provisions
H.R. 6, 21st Century Cures Act, all provisions
H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions
S. 2511, Improving Health Information Technology Act, all provisions
S.2141, TRUST IT Act, all provisions
H.R. 4229, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015, all provisions
Prescription Drug Diversion/Opioid Abuse
Meaningful Use Regulations/Electronic Health Records
Health Savings Accounts - Prescription requirements for over-the-counter medications
Medical Licensure - The Interstate Medical Licensure Compact
Telemedicine
Health system reform
Human trafficking
Health data security
Prescription drug costs
Chronic Care
Prediabetes
Hypertension
Indoor Tanning Salons
Home Blood Pressure Monitoring equipment
Unique Device Identifier inclusion on claim forms
FDA/NIH Modernization
Sunshine/Open Payments
ICD-10
Health Insurance Portability and Accountability Act (HIPAA)
Laboratory developed tests (LDTs)
Precision Medicine
Prescription Drug Monitoring Programs (PDMPs)
Zika virus coding

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office, Office of Natl Drug Control Policy (NDCP), Office of Management & Budget (OMB), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP), Centers For Disease Control & Prevention (CDC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code LBR

16. Specific lobbying issues

Insurance company mergers
Insurance market competition
Drug pricing and access

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 2102, Medicare Diabetes Prevention Act of 2015, all provisions
S. 1131, Medicare Diabetes Prevention Act of 2015, all provisions
H.R. 4442, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, all provisions
S. 2484, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, all provisions
H.R. 4499, Promoting Responsible Opioid Prescribing (PROP) Act of 2016, all provisions
H.R. 2568, Fair Medical Audits Act of 2015, all provisions
S. 1913, Stopping Medication Abuse and Protecting Seniors Act of 2015, all provisions
H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015, provisions relating to payment and delivery reform
H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions
H.R. 6, 21st Century Cures Act, provisions relating to Sunshine/transparency
H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions
H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015, all provisions
S. 2680, Mental Health Reform Act of 2016, all provisions
H.R. 2646, Helping Families in Mental Health Crisis Act of 2015, all provisions
S. 2511, Improving Health Information Technology Act, all provisions
S. 2141, TRUST IT Act, all provisions
S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions
H.R. 4227, Medicare Advantage Bill of Rights Act of 2015, all provisions
S. 2392, Medicare Advantage Bill of Rights Act of 2015, all provisions
Medicare program: Meaningful Use Regulations/Electronic Health Records (EHRs)
Medicare program: EHR interoperability and certification
Medicare program: Electronic prior-authorization
Medicare program: Independent Payment Advisory Board (IPAB) Repeal
Medicare program: Graduate Medical Education
Medicare program: Telemedicine
Medicare program: Telehealth and remote patient monitoring services
Medicare program: Chronic Care
Medicare program: Diabetes Prevention
Medicare program: Comprehensive care for joint replacement
Medicare program: Medicare Part B Drug Pricing/Reimbursement
Medicare program: Medicare Part B Drug Demonstration program
Medicare program: Transitional care management
Medicare program: Medicare Access and CHIP Reauthorization Act (MACRA) implementation
Medicare program: Physician Quality Reporting System (PQRS)
Medicare program: Merit-Based Incentive Payment System (MIPS)
Medicare program: Value-Based Modifier (VBM)
Medicare program: Quality Reporting
Medicare program: Prescription drug diversion and abuse
Medicare program: Physician data
Medicare program: Unique Device Identifier inclusion on claim forms
Medicare program: ACO Improvement Act
Medicare program: Health data security
Medicare program: Protecting Access to Medicare Act (PAMA) implementation
Medicare program: Provider network adequacy and balance billing
Medicare program: Sunshine/Open Payments
Medicare program: Resource use
Medicare program: Health Insurance Portability and Accountability Act (HIPAA)
Medicare program: PECOS/Medicare enrollment
Medicare and Medicaid programs: Alternative payment models
Medicare and Medicaid programs: Home Blood Pressure Monitoring equipment
Medicare and Medicaid programs: ICD-10
Medicare and Medicaid programs: Procedure coding
Medicare and Medicaid programs: Behavioral health management

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office, Office of Natl Drug Control Policy (NDCP), Office of Management & Budget (OMB), Medicare Payment Advisory Commission (MedPAC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TOB

16. Specific lobbying issues

Tobacco control

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TOR

16. Specific lobbying issues

H.R. 865, Good Samaritan Health Professionals Act of 2015, all provisions
Medical Liability Reform

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

S. 2170, Veterans E-Health & Telemedicine Support (VETS) Act of 2015, all provisions
S. 2179, Veteran Care Agreements Rule Enhancement (CARE) Act, all provisions
S. 2646, Veterans Choice Improvement Act of 2016, all provisions
H.R. 1604, Veterans' Mental Health Care Access Act, all provisions
S. 2633, Improving Veterans Access to Care in the Community Act, all provisions
Veterans and telemedicine
VA Choice Program Reform
Scope of Practice
Veterans Choice and Nursing Handbook
Access to Care
Tricare access
Telehealth and remote patient monitoring services
Ethics of medical practice

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA), Defense - Dept of (DOD)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization